Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Jul;37(7):514–519. doi: 10.1136/jmg.37.7.514

Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia

R Thiart 1, C Scholtz 1, J Vergotine 1, C Hoogendijk 1, J N P de Villiers 1, H Nissen 1, K Brusgaard 1, D Gaffney 1, M Hoffs 1, W Vermaak 1, M Kotze 1
PMCID: PMC1734636  PMID: 10882754

Abstract

In South Africa, the high prevalence of familial hypercholesterolaemia (FH) among Afrikaners, Jews, and Indians as a result of founder genes is in striking contrast to its reported virtual absence in the black population in general. In this study, the molecular basis of primary hypercholesterolaemia was studied in 16 Africans diagnosed with FH. DNA analysis using three screening methods resulted in the identification of seven different mutations in the coding region of the low density lipoprotein (LDLR) gene in 10 of the patients analysed. These included a 6 bp deletion (GCGATG) accounting for 28% of defective alleles, and six point mutations (D151H, R232W, R385Q, E387K, P678L, and R793Q) detected in single families. The Sotho patient with missense mutation R232W was also heterozygous for a de novo splicing defect 313+1G→A. Several silent mutations/polymorphisms were detected in the LDLR and apolipoprotein B genes, including a base change (g→t) at nucleotide position −175 in the FP2 LDLR regulatory element. This promoter variant was detected at a significantly higher (p<0.05) frequency in FH patients compared to controls and occurred in cis with mutation E387K in one family. Analysis of four intragenic LDLR gene polymorphisms showed that the same chromosomal background was identified at this locus in the four FH patients with the 6 bp deletion. Detection of the 6 bp deletion in Xhosa, Pedi, and Tswana FH patients suggests that it is an ancient mutation predating tribal separation approximately 3000 years ago.


Keywords: apolipoprotein B; hypercholesterolaemia; low density lipoprotein receptor; mutation

Full Text

The Full Text of this article is available as a PDF (138.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackett P. R., Altmiller D. H., Jelley D., Wilson D. P. FH Tulsa-1 and -2: two unique alleles for familial hypercholesterolemia presenting in an affected two-year-old African-American male. Am J Med Genet. 1995 Nov 20;59(3):300–303. doi: 10.1002/ajmg.1320590307. [DOI] [PubMed] [Google Scholar]
  2. Bottema C. D., Ketterling R. P., Yoon H. S., Sommer S. S. The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians. Am J Hum Genet. 1990 Nov;47(5):835–841. [PMC free article] [PubMed] [Google Scholar]
  3. Ehrenborg E., Clee S. M., Pimstone S. N., Reymer P. W., Benlian P., Hoogendijk C. F., Davis H. J., Bissada N., Miao L., Gagné S. E. Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase gene. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2672–2678. doi: 10.1161/01.atv.17.11.2672. [DOI] [PubMed] [Google Scholar]
  4. Feingold K. R., Grunfeld C. Lipoproteins: are they important components of host defense? Hepatology. 1997 Dec;26(6):1685–1686. doi: 10.1002/hep.510260647. [DOI] [PubMed] [Google Scholar]
  5. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  6. Gagné C., Moorjani S., Torres A. L., Brun D., Lupien P. J. Homozygous familial hypercholesterolaemia. Lancet. 1994 Jan 15;343(8890):177–177. doi: 10.1016/s0140-6736(94)90968-7. [DOI] [PubMed] [Google Scholar]
  7. Haddad L., Day I. N., Hunt S., Williams R. R., Humphries S. E., Hopkins P. N. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred. J Lipid Res. 1999 Jun;40(6):1113–1122. [PubMed] [Google Scholar]
  8. Hobbs H. H., Brown M. S., Goldstein J. L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1(6):445–466. doi: 10.1002/humu.1380010602. [DOI] [PubMed] [Google Scholar]
  9. Hobbs H. H., Russell D. W., Brown M. S., Goldstein J. L. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet. 1990;24:133–170. doi: 10.1146/annurev.ge.24.120190.001025. [DOI] [PubMed] [Google Scholar]
  10. Innerarity T. L., Weisgraber K. H., Arnold K. S., Mahley R. W., Krauss R. M., Vega G. L., Grundy S. M. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6919–6923. doi: 10.1073/pnas.84.19.6919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jensen H. K., Jensen L. G., Hansen P. S., Faergeman O., Gregersen N. High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. Clin Chem. 1996 Aug;42(8 Pt 1):1140–1146. [PubMed] [Google Scholar]
  12. Jensen H. K., Jensen L. G., Hansen P. S., Faergeman O., Gregersen N. Two point mutations (313 + 1G --> A and 313 + 1G --> T) in the splice donor site of intron 3 of the low-density lipoprotein receptor gene are associated with familial hypercholesterolemia. Hum Mutat. 1996;7(3):269–271. doi: 10.1002/(SICI)1098-1004(1996)7:3<269::AID-HUMU13>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  13. Kotze M. J., Langenhoven E., Retief A. E., Steyn K., Marais M. P., Grobbelaar J. J., Oosthuizen C. J., Weich H. F., Benadé A. J. Haplotype associations of three DNA polymorphisms at the human low density lipoprotein receptor gene locus in familial hypercholesterolaemia. J Med Genet. 1987 Dec;24(12):750–755. doi: 10.1136/jmg.24.12.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kotze M. J., Langenhoven E., Warnich L., du Plessis L., Retief A. E. The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners. Ann Hum Genet. 1991 May;55(Pt 2):115–121. doi: 10.1111/j.1469-1809.1991.tb00404.x. [DOI] [PubMed] [Google Scholar]
  15. Kotze M. J., Theart L., Callis M., Peeters A. V., Thiart R., Langenhoven E. Nonradioactive multiplex PCR screening strategy for the simultaneous detection of multiple low-density lipoprotein receptor gene mutations. PCR Methods Appl. 1995 Jun;4(6):352–356. doi: 10.1101/gr.4.6.352. [DOI] [PubMed] [Google Scholar]
  16. Kotze M. J., Thiart R., Loubser O., de Villiers J. N., Santos M., Vargas M. A., Peeters A. V. Mutation analysis reveals an insertional hotspot in exon 4 of the LDL receptor gene. Hum Genet. 1996 Oct;98(4):476–478. doi: 10.1007/s004390050242. [DOI] [PubMed] [Google Scholar]
  17. Krawczak M., Cooper D. N. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet. 1991 Mar;86(5):425–441. doi: 10.1007/BF00194629. [DOI] [PubMed] [Google Scholar]
  18. Leitersdorf E., Hobbs H. H., Fourie A. M., Jacobs M., van der Westhuyzen D. R., Coetzee G. A. Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1988 Nov;85(21):7912–7916. doi: 10.1073/pnas.85.21.7912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marais A. D., Berger G. M. A diversity of genetic hyperlipoproteinaemias in black patients. Experience at the Lipid Clinics at Groote Schuur Hospital and Red Cross War Memorial Children's Hospital, Cape Town. S Afr Med J. 1986 Nov 8;70(10):583–587. [PubMed] [Google Scholar]
  20. Meiner V., Landsberger D., Berkman N., Reshef A., Segal P., Seftel H. C., van der Westhuyzen D. R., Jeenah M. S., Coetzee G. A., Leitersdorf E. A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews. Am J Hum Genet. 1991 Aug;49(2):443–449. [PMC free article] [PubMed] [Google Scholar]
  21. Netea M. G., Demacker P. N., Kullberg B. J., Boerman O. C., Verschueren I., Stalenhoef A. F., van der Meer J. W. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest. 1996 Mar 15;97(6):1366–1372. doi: 10.1172/JCI118556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nissen H., Guldberg P., Hansen A. B., Petersen N. E., Hørder M. Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat. 1996;8(2):168–177. doi: 10.1002/(SICI)1098-1004(1996)8:2<168::AID-HUMU9>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  23. Pimstone S. N., Sun X. M., du Souich C., Frohlich J. J., Hayden M. R., Soutar A. K. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):309–315. doi: 10.1161/01.atv.18.2.309. [DOI] [PubMed] [Google Scholar]
  24. Pullinger C. R., Gaffney D., Gutierrez M. M., Malloy M. J., Schumaker V. N., Packard C. J., Kane J. P. The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds. J Lipid Res. 1999 Feb;40(2):318–327. [PubMed] [Google Scholar]
  25. Rubinsztein D. C., Coetzee G. A., van der Westhuyzen D. R., Langenhoven E., Kotze M. J. Familial defective apolipoprotein-B is rare in hypercholesterolaemic South African Afrikaners, coloureds and Indians. S Afr Med J. 1995 May;85(5):355–357. [PubMed] [Google Scholar]
  26. Seftel H. C., Baker S. G., Sandler M. P., Forman M. B., Joffe B. I., Mendelsohn D., Jenkins T., Mieny C. J. A host of hypercholesterolaemic homozygotes in South Africa. Br Med J. 1980 Sep 6;281(6241):633–636. doi: 10.1136/bmj.281.6241.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Slimane M. N., Pousse H., Maatoug F., Hammami M., Ben Farhat M. H. Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia. Atherosclerosis. 1993 Dec;104(1-2):153–158. doi: 10.1016/0021-9150(93)90186-x. [DOI] [PubMed] [Google Scholar]
  28. Soria L. F., Ludwig E. H., Clarke H. R., Vega G. L., Grundy S. M., McCarthy B. J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989 Jan;86(2):587–591. doi: 10.1073/pnas.86.2.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Steyn K., Kazenellenbogen J. M., Lombard C. J., Bourne L. T. Urbanization and the risk for chronic diseases of lifestyle in the black population of the Cape Peninsula, South Africa. J Cardiovasc Risk. 1997 Apr;4(2):135–142. [PubMed] [Google Scholar]
  30. Sun X. M., Patel D. D., Bhatnagar D., Knight B. L., Soutar A. K. Characterization of a splice-site mutation in the gene for the LDL receptor associated with an unpredictably severe clinical phenotype in English patients with heterozygous FH. Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):219–227. doi: 10.1161/01.atv.15.2.219. [DOI] [PubMed] [Google Scholar]
  31. Südhof T. C., Goldstein J. L., Brown M. S., Russell D. W. The LDL receptor gene: a mosaic of exons shared with different proteins. Science. 1985 May 17;228(4701):815–822. doi: 10.1126/science.2988123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Theart L., Kotze M. J., Langenhoven E., Loubser O., Peeters A. V., Lintott C. J., Scott R. S. Screening for mutations in exon 4 of the LDL receptor gene: identification of a new deletion mutation. J Med Genet. 1995 May;32(5):379–382. doi: 10.1136/jmg.32.5.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Top B., Uitterlinden A. G., van der Zee A., Kastelein J. J., Leuven J. A., Havekes L. M., Frants R. R. Absence of mutations in the promoter region of the low density lipoprotein receptor gene in a large number of familial hypercholesterolaemia patients as revealed by denaturing gradient gel electrophoresis. Hum Genet. 1992 Jul;89(5):561–565. doi: 10.1007/BF00219185. [DOI] [PubMed] [Google Scholar]
  34. Varret M., Rabès J. P., Saint-Jore B., Cenarro A., Marinoni J. C., Civeira F., Devillers M., Krempf M., Coulon M., Thiart R. A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. Am J Hum Genet. 1999 May;64(5):1378–1387. doi: 10.1086/302370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vermaak W. J., Ubbink J. B., Delport R., Becker P. J., Bissbort S. H., Ungerer J. P. Ethnic immunity to coronary heart disease? Atherosclerosis. 1991 Aug;89(2-3):155–162. doi: 10.1016/0021-9150(91)90056-9. [DOI] [PubMed] [Google Scholar]
  36. von Haeseler A., Sajantila A., Päbo S. The genetical archaeology of the human genome. Nat Genet. 1996 Oct;14(2):135–140. doi: 10.1038/ng1096-135. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES